Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Morgan Stanley (MS), Wells Fargo & Co (WFC): One Reason Banks Are Underperforming Today

U.S. stocks are slipping this morning, with the S&P 500 (INDEXSP:.INX) and the narrower, price-weighted Dow Jones Industrial Average (INDEXDJX:.DJI) down 0.43% and 0.08%, respectively, at 10:20 a.m. EDT.

The macro view
One possible explanation for this morning’s decline is the June employment data released by payroll processor ADP, according to which private employers added 188,000 jobs last month. That figure easily trumps the 160,000 forecast obtained in a Reuters poll of economists.

Morgan Stanley

Why would stronger-than-expected employment numbers push stock prices down? Investors may figure that this data will bolster the Fed’s case for reining in its monthly bond purchases, a.k.a. “quantitative easing,” which have been a source of support for the stock and bond markets. It’s not clear what any of this has to do with equities’ long-term fundamental value, but that’s the logic of Wall Street.

Of course, the ADP numbers are a bit of a sideshow while the market waits for the June employment report from the Bureau of Labor Statistics, due at 8:30 a.m. EDT on Friday. (We’ll have you covered Friday morning with the proper context to understand those numbers.)

The micro view
Bank capital requirements were on the agenda of yesterday’s Federal Reserve board meeting, and bankers may not be pleased with the outcome. The Fed’s mandate includes preserving the integrity of the U.S. banking system, and the organization has a supervisory role, particularly with regard to the largest, “systemically important” institutions.

The Fed will require banks to comply with multiple capital requirements. Most of these are part of the international norms set out in the new Basel III framework on capital adequacy. Basel III is based on the notion of “risk-adjusted assets,” according to which banks should set aside different amounts of capital against different assets, depending on the assets’ risk level. For example, U.S. Treasuries — considered to be the safest asset — require no capital provision, whereas the riskiest loans might require a 100% capital provision.

However, the Fed is likely to add a simpler leverage ratio that makes no adjustment for perceived riskiness and is therefore immune to banks fiddling with their risk models to “optimize” their risk-adjusted assets. The leverage ratio is calculated based on total assets. The Fed is also considering adding a capital charge for banks that are heavily reliant on wholesale funding — repo markets are a less stable source of funds than bank deposits. This would penalize firms like Morgan Stanley (NYSE:MS) and Goldman Sachs Group Inc (NYSE:GS).

For banks like Wells Fargo & Co (NYSE:WFC), the news was mixed. On the one hand, the Fed adjusted its risk weights for mortgages downward, requiring mortgage lenders to hold less capital against them, but it didn’t reduce the capital charge for “mortgage servicing rights,” which represent the value of future servicing fees.

Bank share investors need to watch this space: As these regulations are finalized, shares will be rerated.

The article 1 Reason Banks Are Underperforming Today originally appeared on is written by Alex Dumortier, CFA.

Fool contributor Alex Dumortier, CFA has no position in any stocks mentioned; you can follow him on LinkedIn. The Motley Fool recommends Goldman Sachs (NYSE:GS) and Wells Fargo. The Motley Fool owns shares of Wells Fargo.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!